Parkman Healthcare Partners’s Compass Pathways CMPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-554,411
Closed -$3.07M – 84
2026
Q1
$3.07M Buy
554,411
+454,939
+457% +$3.06M 0.32% 76
2025
Q4
$686K Sell
99,472
-528
-0.5% -$3.22K 0.07% 95
2025
Q3
$573K Buy
+100,000
New +$449K 0.06% 88

Other funds holding CMPS

Parkman Healthcare Partners's CMPS Position: Q2 2026 in Review

Parkman Healthcare Partners sold out of Compass Pathways (CMPS) in Q2 2026, closing a stake of 554,411 shares — an estimated $3.07M sold.

Parkman Healthcare Partners first reported a position in CMPS in Q3 2025 and held it in 3 quarters. The position peaked at $3.07M in Q1 2026. 224 funds tracked by Wall St. Rank hold CMPS as of Q2 2026.

  • Parkman Healthcare Partners reported no remaining Compass Pathways position as of Q2 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 554,411 Compass Pathways shares in Q2 2026, an estimated $3.07M.
  • Parkman Healthcare Partners first reported a position in Compass Pathways in Q3 2025 and held it in 3 quarters.
  • Parkman Healthcare Partners's Compass Pathways position peaked at $3.07M in Q1 2026.
  • 224 funds tracked by Wall St. Rank held Compass Pathways as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.